These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 18307623

  • 1. Are nonsustained ventricular tachycardias predictive of major arrhythmias in patients with dilated cardiomyopathy on optimal medical treatment?
    Zecchin M, Di Lenarda A, Gregori D, Merlo M, Pivetta A, Vitrella G, Sabbadini G, Mestroni L, Sinagra G.
    Pacing Clin Electrophysiol; 2008 Mar; 31(3):290-9. PubMed ID: 18307623
    [Abstract] [Full Text] [Related]

  • 2. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G, Ciaccheri M, Cecchi F, Troiani V, Nannini M, Marconi P, Olivotto J, Montereggi A, Dolara A.
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [Abstract] [Full Text] [Related]

  • 3. Prognostic role of non-sustained ventricular tachycardia in a large cohort of patients with idiopathic dilated cardiomyopathy.
    Zecchin M, Di Lenarda A, Gregori D, Moretti M, Driussi M, Aleksova A, Chersevani D, Sabbadini G, Sinagra G.
    Ital Heart J; 2005 Sep; 6(9):721-7. PubMed ID: 16212073
    [Abstract] [Full Text] [Related]

  • 4. [The predictive value for major arrhythmic events of ventricular arrhythmias, particularly nonsustained ventricular tachycardias, in the subacute phase of a fibrinolyzed infarct. An analysis of GISSI-2 data. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
    Giani P, Avanzini F, Bagliani G, Galati A, Pucci P, Santoro E.
    G Ital Cardiol; 1995 Jan; 25(1):77-87. PubMed ID: 7642014
    [Abstract] [Full Text] [Related]

  • 5. Role of nonsustained ventricular tachycardia and programmed ventricular stimulation for risk stratification in patients with idiopathic dilated cardiomyopathy.
    Becker R, Haass M, Ick D, Krueger C, Bauer A, Senges-Becker JC, Voss F, Hilbel T, Niroomand F, Katus HA, Schoels W.
    Basic Res Cardiol; 2003 Jul; 98(4):259-66. PubMed ID: 12835955
    [Abstract] [Full Text] [Related]

  • 6. Ventricular repolarization dynamicity provides independent prognostic information toward major arrhythmic events in patients with idiopathic dilated cardiomyopathy.
    Iacoviello M, Forleo C, Guida P, Romito R, Sorgente A, Sorrentino S, Catucci S, Mastropasqua F, Pitzalis M.
    J Am Coll Cardiol; 2007 Jul 17; 50(3):225-31. PubMed ID: 17631214
    [Abstract] [Full Text] [Related]

  • 7. Arrhythmias and sudden death after dynamic cardiomyoplasty.
    Bocchi EA, Moreira LF, de Moraes AV, Bacal F, Sosa E, Stolf NA, Bellotti G, Jatene AD, Pilleggi F.
    Circulation; 1994 Nov 17; 90(5 Pt 2):II107-11. PubMed ID: 7955235
    [Abstract] [Full Text] [Related]

  • 8. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J, Piekarz J, Rydlewska A, Majewski J, Senderek T, Ząbek A, Małecka B.
    Kardiol Pol; 2012 Nov 17; 70(12):1264-75. PubMed ID: 23264245
    [Abstract] [Full Text] [Related]

  • 9. Long runs of non-sustained ventricular tachycardia on 24-hour ambulatory electrocardiogram predict major arrhythmic events in patients with idiopathic dilated cardiomyopathy.
    Grimm W, Christ M, Maisch B.
    Pacing Clin Electrophysiol; 2005 Jan 17; 28 Suppl 1():S207-10. PubMed ID: 15683498
    [Abstract] [Full Text] [Related]

  • 10. [Predictive value of QT interval dynamicity for sudden death in patients with idiopathic dilated cardiomyopathy].
    Bao MW, Tan TT, Yu SB, Chen K, Huang CX.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Dec 17; 38(12):1093-7. PubMed ID: 21215145
    [Abstract] [Full Text] [Related]

  • 11. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study.
    Grimm W, Christ M, Bach J, Müller HH, Maisch B.
    Circulation; 2003 Dec 09; 108(23):2883-91. PubMed ID: 14623812
    [Abstract] [Full Text] [Related]

  • 12. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
    Adabag AS, Casey SA, Kuskowski MA, Zenovich AG, Maron BJ.
    J Am Coll Cardiol; 2005 Mar 01; 45(5):697-704. PubMed ID: 15734613
    [Abstract] [Full Text] [Related]

  • 13. The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy.
    Zecchin M, Di Lenarda A, Proclemer A, Faganello G, Facchin D, Petz E, Sinagra G.
    Europace; 2004 Sep 01; 6(5):400-6. PubMed ID: 15294264
    [Abstract] [Full Text] [Related]

  • 14. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Gimeno JR, Tomé-Esteban M, Lofiego C, Hurtado J, Pantazis A, Mist B, Lambiase P, McKenna WJ, Elliott PM.
    Eur Heart J; 2009 Nov 01; 30(21):2599-605. PubMed ID: 19689975
    [Abstract] [Full Text] [Related]

  • 15. Nonsustained ventricular tachycardia: where do we stand?
    Katritsis DG, Camm AJ.
    Eur Heart J; 2004 Jul 01; 25(13):1093-9. PubMed ID: 15231366
    [Abstract] [Full Text] [Related]

  • 16. Heart rate turbulence and other autonomic risk markers for arrhythmia risk stratification in dilated cardiomyopathy.
    Klingenheben T, Ptaszynski P, Hohnloser SH.
    J Electrocardiol; 2008 Jul 01; 41(4):306-11. PubMed ID: 18342881
    [Abstract] [Full Text] [Related]

  • 17. Incidence and predictors of sudden cardiac death during long-term follow-up in patients with dilated cardiomyopathy on optimal medical therapy.
    Zecchin M, Lenarda AD, Bonin M, Mazzone C, Zanchi C, Di Chiara C, Davanzo M, Scherl G, Sabbadini G, Sinagra G.
    Ital Heart J; 2001 Mar 01; 2(3):213-21. PubMed ID: 11305533
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
    Salerno-Uriarte JA, De Ferrari GM, Klersy C, Pedretti RF, Tritto M, Sallusti L, Libero L, Pettinati G, Molon G, Curnis A, Occhetta E, Morandi F, Ferrero P, Accardi F, ALPHA Study Group Investigators.
    J Am Coll Cardiol; 2007 Nov 06; 50(19):1896-904. PubMed ID: 17980258
    [Abstract] [Full Text] [Related]

  • 19. [The natural history of dilated cardiomyopathy: a review of the Heart Muscle Disease Registry of Trieste].
    Di Lenarda A, Pinamonti B, Mestroni L, Salvi A, Sabbadini G, Gregori D, Perkan A, Zecchin M, Carniel E, Bussani R, Silvestri F, Morgera T, Camerini F, Sinagra G, Gruppo di Studio sulle Malattie del Miocardio.
    Ital Heart J Suppl; 2004 Apr 06; 5(4):253-66. PubMed ID: 15346692
    [Abstract] [Full Text] [Related]

  • 20. Prophylactic implantable cardioverter defibrillator therapy in dilated cardiomyopathy: impact of left ventricular function.
    Schaer BA, Ammann P, Sticherling C, Zellweger MJ, Cron TA, Osswald S.
    Int J Cardiol; 2006 Mar 22; 108(1):26-30. PubMed ID: 16516695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.